UK markets close in 6 hours 30 minutes

Aldeyra Therapeutics, Inc. (ALDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.1200-0.0400 (-0.96%)
At close: 04:00PM EDT
4.1600 +0.04 (+0.97%)
After hours: 07:44PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-30,009
-37,543
-62,025
-57,776
-37,554
Depreciation & amortisation
256.44
262.78
258.707
264.18
56.221
Deferred income taxes
-
-
-
0
-479.265
Stock-based compensation
3,111
5,753
8,289
7,108
7,084
Change in working capital
-4,367
861.18
-3,444
7,439
-8,830
Accounts payable
-149.386
1,204
-886.077
638.064
-426.664
Other working capital
-30,855
-30,326
-56,654
-42,564
-37,493
Other non-cash items
325.185
354.193
331.15
409.471
2,320
Net cash provided by operating activities
-30,855
-30,326
-56,637
-42,556
-37,493
Cash flows from investing activities
Investments in property, plant and equipment
-9.529
-
-16.317
-7.806
-
Purchases of investments
-30,377
0
-92,938
0
-5,776
Sales/maturities of investments
0
30,000
63,000
0
34,800
Net cash used for investing activities
-30,377
30,000
-29,955
-7.806
29,024
Cash flows from financing activities
Common stock issued
-
-
0
189,812
40,717
Other financing activities
-123.186
-1,575
-
-
-
Net cash used provided by (used for) financing activities
-1,305
-1,270
1,220
194,496
41,902
Net change in cash
-62,536
-1,596
-85,372
151,933
33,432
Cash at beginning of period
165,028
144,419
229,791
77,858
44,426
Cash at end of period
102,492
142,823
144,419
229,791
77,858
Free cash flow
Operating cash flow
-30,855
-30,326
-56,637
-42,556
-37,493
Capital expenditure
-9.529
-
-16.317
-7.806
-
Free cash flow
-30,855
-30,326
-56,654
-42,564
-37,493